dsm-firmenich debuts "The Longevity Shift" at SupplySide Global 2025

In a recent press release, dsm-firmenich announced that the company would be debuting an immersive experience at the upcoming SupplySide Global 2025 event.¹ The conference will take place in Las Vegas, Nevada, between October 29 to October 30, 2025. Attendees will be able to visit dsm-firmenich’s booth at Booth #6264 for the interactive installation regarding longevity and the company’s offerings that may help with healthier lifestyles.

The company’s booth component is called “The Longevity Shift” and was created to bring new ideas on the topic of aging and how longevity and health play into the concept. Paulo-Henrique Santos, Associate Director, Dietary Supplements, North America, dsm-firmenich, explained, “Throughout history, people have obsessed with how long they will live. But given that many of us will spend the last decade of our lives in ill-health, the more important question is: how long can we stay healthy? That’s the challenge we’re tackling at dsm-firmenich—and one we’re inviting the industry to explore first-hand in The Longevity Shift. This isn't just another booth visit—it's a transformative exploration of how science is revolutionizing the way we approach aging. Visitors are advised to pre-book a 20-minute slot or they can walk in during the show, subject to availability.”¹

dsm-firmenich is an official sponsor of the Health Longevity category at SupplySide Global. At the conference, the organization will highlight different aspects of aging, which will include chronic inflammation, cellular senescence, and two additional hallmarks that will be unveiled for the first time at SupplySide Global 2025. dsm-firmenich offers a Healthy Longevity platform that provides “A complete ecosystem of nutritional solutions, scientific expertise, and innovation services designed to help dietary supplement brands develop effective health expectancy products.”¹

The company’s press release mentions that consumers today are becoming more interested in prevention, such as maintaining physical strength, resilience against everyday health challenges, and mental sharpness.¹ At SupplySide Global 2025, dsm-firmenich will highlight their product portfolio offerings that may help with this rising interest.

Kristen Germana, Senior Director, Marketing & Business Development, dsm-firmenich, remarks, “Healthy longevity is part of the wider preventative health movement. From brain health to gut health to inflammation, consumers want holistic solutions that help them live better for longer. At SupplySide Global, we’ll show how dsm-firmenich can empower brands to deliver exactly that.”¹

Capsule-Based Synbiotic-Butyrate May Provide IBS Symptom Relief

A clinical study² examined the effects of a combination of pre- and probiotics and microencapsulated sodium butyrate on irritable bowel syndrome (IBS) symptoms. The probiotics used in the study were Lactocaseibacillus rhamnosus DSM 26357, Lactobacillus acidophilus DSM 32418, Bifidobacterium longum DSM 32946, Bifidobacterium bifidum DSM 32403, and Bifidobacterium lactis DSM 32269, prepared and supplied by dsm-firmenich, sourced from its Humiome biotics portfolio. Small amounts of prebiotic short-chain fructooligosaccharides (scFOSs) were also included as well. The study, “Efficacy and Safety of a Mixture of Microencapsulated Sodium Butyrate, Probiotics, and Short Chain Fructooligosaccharides in Patients with Irritable Bowel Syndrome—A Randomized, Double-Blind,Placebo-Controlled Study,” was published in Journal of Clinical Medicine in December 2024.

Highlighted results include:

• After four weeks, 64.7% of the test group reported adequate symptom relief, compared with 42.0% of the placebo group
• At 12 weeks, 5.9% of participants in the test group reported a worsening of symptoms compared with 16% of the placebo group
• At 12 weeks, the test group reported significantly less ‘urgency to defecate’ compared with the placebo group
• No differences in levels of cytokines were seen between the groups

The researchers concluded that the synbiotic-butyrate mixture was safe and well-tolerated and may be beneficial in managing gastrointestinal symptoms in patients with IBS.

References

1. DSM-Firmenich brings first-of-its-kind immersive “longevity shift” experience to Supplyside Global 2025: DSM-Firmenich Health, Nutrition & Care https://www.dsm-firmenich.com/en/businesses/health-nutrition-care/news/press-releases/2025-09-15-dsm-firmenich-brings-first-of-its-kind-immersive-longevity-shift-experience-to-supplyside-global-2025.html (accessed Oct 13, 2025).
2. McEvoy, E. Clinical study demonstrates capsule-based synbiotic-butyrate effective for IBS symptom relief https://www.nutritionaloutlook.com/view/clinical-study-demonstrates-capsule-based-synbiotic-butyrate-effective-for-ibs-symptom-relief (accessed Oct 13, 2025).